Pegasys (Genentech, Inc.)


Welcome to the PulseAid listing for the Pegasys drug offered from Genentech, Inc.. This Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: peginterferon alfa-2a
SUBSTANCE NAME: PEGINTERFERON ALFA-2A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Interferon alpha [EPC],peginterferon alfa-2a [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2002-10-16
END MARKETING DATE: 0000-00-00


Pegasys HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPegasys from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 180(ug/mL)
START MARKETING DATE: 2002-10-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0004-0350_1b19b557-1e64-485f-8200-9b98ad757e6b
PRODUCT NDC: 0004-0350
APPLICATION NUMBER: BLA103964

Other PEGINTERFERON ALFA-2A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.Pegasys